김형지 교수

논문

• [주저자]
  1. Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia. Curr Alzheimer Res. 2020
  2. The cerebellum could serve as a potential imaging biomarker of dementia conversion in patients with amyloid-negative amnestic mild cognitive impairment. Eur J Neurol. 2021
  3. Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment [published online ahead of print, 2021 Jun 16]. Alzheimer Dis Assoc Disord. 2021
  4. Crossed Hemispheric Accumulation of β-Amyloid and Tau Protein in a Patient With Typical Alzheimer Disease [published online ahead of print, 2021 Jun 16]. Alzheimer Dis Assoc Disord. 2021
  5. Development of a Low-Molecular-Weight Aβ42 Detection System Using a Enzyme-Linked Peptide Assay. Biomolecules. 2021
  6. Patterns of Focal Amyloid Deposition Using 18F-Florbetaben PET in Patients with Cognitive Impairment. Diagnostics (Basel). 2022
  7. The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment. Alzheimers Res Ther. 2022
  8. Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers. Alzheimers Dement (Amst). 2023
  9. Magnetic resonance image-based brain age as a discriminator of dementia conversion in patients with amyloid-negative amnestic mild cognitive impairment. Sci Rep. 2023
  10. A Patient With Fahr's Disease Who Presented Prominent Visuospatial Dysfunction. Dement Neurocogn Disord. 2023
  
  [공동저자]
  11. Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice. Pharmaceuticals (Basel). 2021
  12. Efficacies of Cognitive Interventions in the Elderly with Subjective Cognitive Decline: A Prospective, Three-Arm, Controlled Trial. J Clin Neurol. 2020
  13. FDG-PET patterns associated with ideomotor apraxia and imitation apraxia in patients with corticobasal syndrome. Parkinsonism Relat Disord. 2021
  14. The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease. Sci Rep. 2021
  15. False Memory and Alzheimer's Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET. Dement Geriatr Cogn Dis Extra. 2021
  16. A Case of a Patient Who Presented with Rapidly Progressive Dementia and Capricious RT-QuIC Results. Dement Neurocogn Disord. 2020
  17. Patient with Creutzfeldt-Jakob Disease Who Presented Symptom Fluctuation J Korean Neurol Assoc. 2021
  18. Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial [published online ahead of print, 2021 Sep 10]. Dement Geriatr Cogn Disord. 2021
  19. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy. J Alzheimers Dis. 2022
  20. Quantitative and Qualitative Differences of Action Verbal Fluency between Young and Older Adults. Dement Geriatr Cogn Disord. 2021
  21. Relationship between disproportionately enlarged subarachnoid-space hydrocephalus and white matter tract integrity in normal pressure hydrocephalus. Sci Rep. 2023